Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dad13e34a819e3e9f39aba5fc721594 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
filingDate |
2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43409f42ad6cd5148672e55143354838 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_422ee5b01c725603cec703ea2befcc65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c347e0a50d7fd8787cbb3b585fccab3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed7ab4cd9b9533e74af606a2bd243c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38741cf5019d4bbcb0d5ecebcc695410 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d80f6a38e607d33f93753bdb9b0a5935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea386e3b76de1e502ef00abedb949ed5 |
publicationDate |
2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9562219-B2 |
titleOfInvention |
Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer |
abstract |
Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer. |
priorityDate |
2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |